Sarcoma drug combo trial halted early – safety data collected
NCT ID NCT05116254
First seen Jan 26, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This early-phase trial tested a new drug (AZD1390) with or without another drug (durvalumab) plus radiation in 12 adults with soft tissue sarcoma before surgery. The goal was to check safety, side effects, and wound healing. The study was stopped early, but the information gathered helps guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Antoni van Leeuwenhoek
Amsterdam, 1066CX, Netherlands
Conditions
Explore the condition pages connected to this study.